- Home
- PSFE vs COLL Comparison
PSFE vs COLL Comparison
Compare PSFE & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSFE
- COLL
- Stock Information
- Founded
- PSFE 1996
- COLL 2002
- Country
- PSFE United Kingdom
- COLL United States
- Employees
- PSFE N/A
- COLL N/A
- Industry
- PSFE Business Services
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- PSFE Consumer Discretionary
- COLL Health Care
- Exchange
- PSFE Nasdaq
- COLL Nasdaq
- Market Cap
- PSFE 1.1B
- COLL 1.0B
- IPO Year
- PSFE N/A
- COLL 2015
- Fundamental
- Price
- PSFE $19.24
- COLL $29.13
- Analyst Decision
- PSFE Sell
- COLL Strong Buy
- Analyst Count
- PSFE 4
- COLL 5
- Target Price
- PSFE $19.50
- COLL $43.60
- AVG Volume (30 Days)
- PSFE 410.1K
- COLL 304.0K
- Earning Date
- PSFE 03-04-2025
- COLL 02-27-2025
- Dividend Yield
- PSFE N/A
- COLL N/A
- EPS Growth
- PSFE N/A
- COLL 757.11
- EPS
- PSFE N/A
- COLL 2.16
- Revenue
- PSFE $1,699,306,000.00
- COLL $599,245,000.00
- Revenue This Year
- PSFE $9.73
- COLL $13.25
- Revenue Next Year
- PSFE $6.89
- COLL $17.67
- P/E Ratio
- PSFE N/A
- COLL $13.47
- Revenue Growth
- PSFE 8.22
- COLL 9.62
- 52 Week Low
- PSFE $11.94
- COLL $28.39
- 52 Week High
- PSFE $26.25
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- PSFE 47.76
- COLL 37.61
- Support Level
- PSFE $18.33
- COLL $29.39
- Resistance Level
- PSFE $21.01
- COLL $30.39
- Average True Range (ATR)
- PSFE 1.21
- COLL 1.00
- MACD
- PSFE -0.17
- COLL -0.24
- Stochastic Oscillator
- PSFE 15.74
- COLL 11.04
About PSFE Paysafe Limited
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet, and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.